Published in Int J Cancer on March 01, 2008
Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk. Lancet Oncol (2011) 3.01
Nevus density and melanoma risk in women: a pooled analysis to test the divergent pathway hypothesis. Int J Cancer (2009) 1.13
Pooled cohort study on height and risk of cancer and cancer death. Cancer Causes Control (2013) 0.88
Adult height and head and neck cancer: a pooled analysis within the INHANCE Consortium. Eur J Epidemiol (2013) 0.84
Height and bone mineral density are associated with naevus count supporting the importance of growth in melanoma susceptibility. PLoS One (2015) 0.81
Obesity and risks for malignant melanoma and non-melanoma skin cancer: results from a large Danish prospective cohort study. J Invest Dermatol (2014) 0.78
Height as an independent anthropomorphic risk factor for colorectal cancer. Eur J Gastroenterol Hepatol (2014) 0.76
Height, height-related SNPs, and risk of non-melanoma skin cancer. Br J Cancer (2016) 0.75
Associations between childhood height and morphologically different variants of melanoma in adulthood. Eur J Cancer (2016) 0.75
Body mass index, height and early-onset basal cell carcinoma in a case-control study. Cancer Epidemiol (2016) 0.75
Childhood Body Size and the Risk of Malignant Melanoma in Adulthood. Am J Epidemiol (2017) 0.75
Role of BMI and hormone therapy in melanoma risk: a case-control study. J Cancer Res Clin Oncol (2017) 0.75
Height and lung cancer risk: A meta-analysis of observational studies. PLoS One (2017) 0.75
Hospital volume and surgical mortality in the United States. N Engl J Med (2002) 25.79
Surgeon volume and operative mortality in the United States. N Engl J Med (2003) 16.97
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis. Nature (2011) 13.23
Survival for eight major cancers and all cancers combined for European adults diagnosed in 1995-99: results of the EUROCARE-4 study. Lancet Oncol (2007) 9.57
Cancer survival in five continents: a worldwide population-based study (CONCORD). Lancet Oncol (2008) 7.18
Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet (2009) 7.07
Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med (2006) 7.01
Mapping cis- and trans-regulatory effects across multiple tissues in twins. Nat Genet (2012) 6.97
The architecture of gene regulatory variation across multiple human tissues: the MuTHER study. PLoS Genet (2011) 5.95
Factors associated with incomplete colonoscopy: a population-based study. Gastroenterology (2007) 5.30
Educational epidemiology: applying population-based design and analytic approaches to study medical education. JAMA (2004) 5.15
Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer. Nat Genet (2009) 5.14
A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33. Nat Genet (2010) 4.89
A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood (2002) 4.59
New common variants affecting susceptibility to basal cell carcinoma. Nat Genet (2009) 4.15
Genetic variation in TNF and IL10 and risk of non-Hodgkin lymphoma: a report from the InterLymph Consortium. Lancet Oncol (2006) 4.13
Indoor tanning and risk of melanoma: a case-control study in a highly exposed population. Cancer Epidemiol Biomarkers Prev (2010) 3.95
A multi-stage genome-wide association study of bladder cancer identifies multiple susceptibility loci. Nat Genet (2010) 3.93
Model-based clustering of DNA methylation array data: a recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions. BMC Bioinformatics (2008) 3.89
Autoimmune disorders and risk of non-Hodgkin lymphoma subtypes: a pooled analysis within the InterLymph Consortium. Blood (2008) 3.81
Bleeding and perforation after outpatient colonoscopy and their risk factors in usual clinical practice. Gastroenterology (2008) 3.71
Detectable clonal mosaicism and its relationship to aging and cancer. Nat Genet (2012) 3.69
The population dynamics of cancer: a Darwinian perspective. Int J Epidemiol (2006) 3.59
Hospital volume, length of stay, and readmission rates in high-risk surgery. Ann Surg (2003) 3.31
The risk of missed diagnosis of acute myocardial infarction associated with emergency department volume. Ann Emerg Med (2006) 3.29
Risk of Guillain-Barré syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study. Lancet Infect Dis (2013) 3.27
Survival differences between patients with scalp or neck melanoma and those with melanoma of other sites in the Surveillance, Epidemiology, and End Results (SEER) program. Arch Dermatol (2008) 3.11
Risk-treatment mismatch in the pharmacotherapy of heart failure. JAMA (2005) 3.05
Hospital volume and late survival after cancer surgery. Ann Surg (2007) 2.93
DNA methylation, isocitrate dehydrogenase mutation, and survival in glioma. J Natl Cancer Inst (2010) 2.87
Tumor necrosis factor (TNF) and lymphotoxin-alpha (LTA) polymorphisms and risk of non-Hodgkin lymphoma in the InterLymph Consortium. Am J Epidemiol (2010) 2.86
Association between colonoscopy and colorectal cancer mortality in a US cohort according to site of cancer and colonoscopist specialty. J Clin Oncol (2012) 2.77
Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet (2009) 2.76
Primary care physician workforce and Medicare beneficiaries' health outcomes. JAMA (2011) 2.73
Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma. Nat Genet (2009) 2.73
Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst (2003) 2.70
Genome-wide association study identifies variants at 9p21 and 22q13 associated with development of cutaneous nevi. Nat Genet (2009) 2.65
Clinicopathological features of and risk factors for multiple primary melanomas. JAMA (2005) 2.62
Allogeneic cytotoxic T-cell therapy for EBV-positive posttransplantation lymphoproliferative disease: results of a phase 2 multicenter clinical trial. Blood (2007) 2.61
Vitamin D status and skin cancer risk independent of time outdoors: 11-year prospective study in an Australian community. J Invest Dermatol (2012) 2.58
Association between colonoscopy rates and colorectal cancer mortality. Am J Gastroenterol (2010) 2.56
Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS (2005) 2.56
Rice consumption and urinary arsenic concentrations in U.S. children. Environ Health Perspect (2012) 2.44
Human papillomavirus infection and incidence of squamous cell and basal cell carcinomas of the skin. J Natl Cancer Inst (2006) 2.40
A case-control study of smoking and bladder cancer risk: emergent patterns over time. J Natl Cancer Inst (2009) 2.40
Arsenic, organic foods, and brown rice syrup. Environ Health Perspect (2012) 2.37
Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. Nat Genet (2010) 2.37
Epidemiologic evidence on mobile phones and tumor risk: a review. Epidemiology (2009) 2.35
Proliferation of prenatal ultrasonography. CMAJ (2010) 2.33
Sun exposure and melanoma risk at different latitudes: a pooled analysis of 5700 cases and 7216 controls. Int J Epidemiol (2009) 2.32
Race and surgical mortality in the United States. Ann Surg (2006) 2.31
The use of the propensity score for estimating treatment effects: administrative versus clinical data. Stat Med (2005) 2.31
Variation in nursing home antipsychotic prescribing rates. Arch Intern Med (2007) 2.30
Alcohol consumption and risk of non-Hodgkin lymphoma: a pooled analysis. Lancet Oncol (2005) 2.27
Use of p16-INK4A overexpression to increase the specificity of human papillomavirus testing: a nested substudy of the NTCC randomised controlled trial. Lancet Oncol (2008) 2.24
Mobile phone use and risk of glioma in adults: case-control study. BMJ (2006) 2.20
Effect of specific allergen inhalation on serum adiponectin in human asthma. Chest (2008) 2.18
Talcum powder, chronic pelvic inflammation and NSAIDs in relation to risk of epithelial ovarian cancer. Int J Cancer (2008) 2.14
Implications of LINE1 methylation for bladder cancer risk in women. Clin Cancer Res (2010) 2.10
Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample. J Natl Cancer Inst (2005) 2.10
Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis (2005) 2.08
Which fish should I eat? Perspectives influencing fish consumption choices. Environ Health Perspect (2012) 2.06
Identifying individuals at high risk of melanoma: a practical predictor of absolute risk. J Clin Oncol (2006) 2.05
Diet and melanoma in a case-control study. Cancer Epidemiol Biomarkers Prev (2004) 2.05
Rice consumption contributes to arsenic exposure in US women. Proc Natl Acad Sci U S A (2011) 2.03
Non-Hodgkin lymphoma and obesity: a pooled analysis from the InterLymph Consortium. Int J Cancer (2008) 2.01
Do cancer centers designated by the National Cancer Institute have better surgical outcomes? Cancer (2005) 1.99
Common genetic polymorphisms modify the effect of smoking on absolute risk of bladder cancer. Cancer Res (2013) 1.99
Proliferation of cardiac technology in Canada: a challenge to the sustainability of Medicare. Circulation (2006) 1.96
Regional intensity of vascular care and lower extremity amputation rates. J Vasc Surg (2013) 1.95
Epigenetic profiling reveals etiologically distinct patterns of DNA methylation in head and neck squamous cell carcinoma. Carcinogenesis (2009) 1.94
Selenium and colorectal adenoma: results of a pooled analysis. J Natl Cancer Inst (2004) 1.93
Polymorphisms and haplotypes in folate-metabolizing genes and risk of non-Hodgkin lymphoma. Blood (2004) 1.93
Life expectancy after an index hospitalization for patients with heart failure: a population-based study. Am Heart J (2008) 1.92
DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer. J Clin Oncol (2011) 1.92
Treatment of Epstein-Barr-virus-positive post-transplantation lymphoproliferative disease with partly HLA-matched allogeneic cytotoxic T cells. Lancet (2002) 1.91
Association of Helicobacter pylori infection with reduced risk for esophageal cancer is independent of environmental and genetic modifiers. Gastroenterology (2010) 1.91
Hepatitis C and non-Hodgkin lymphoma among 4784 cases and 6269 controls from the International Lymphoma Epidemiology Consortium. Clin Gastroenterol Hepatol (2008) 1.91
Melanoma of the small intestine. Lancet Oncol (2009) 1.88
Male-pattern baldness susceptibility locus at 20p11. Nat Genet (2008) 1.87
Cigarette smoking and risk of non-Hodgkin lymphoma: a pooled analysis from the International Lymphoma Epidemiology Consortium (interlymph). Cancer Epidemiol Biomarkers Prev (2005) 1.87
Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet (2013) 1.85
Survival after hepatic resection of colorectal cancer metastases: a national experience. Cancer (2009) 1.81
19p13.1 is a triple-negative-specific breast cancer susceptibility locus. Cancer Res (2012) 1.81
Diabetes mellitus and pancreatic cancer in a population-based case-control study in the San Francisco Bay Area, California. Cancer Epidemiol Biomarkers Prev (2006) 1.81
Population-based study of natural variation in the melanocortin-1 receptor gene and melanoma. Cancer Res (2006) 1.80
Body mass index, leptin and leptin receptor polymorphisms, and non-hodgkin lymphoma. Cancer Epidemiol Biomarkers Prev (2004) 1.80
A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma. Int J Epidemiol (2006) 1.80